Literature DB >> 29700498

Industry embraces virtual trial platforms.

Elie Dolgin.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29700498     DOI： 10.1038/nrd.2018.66

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Advancing the Use of Mobile Technologies in Clinical Trials: Recommendations from the Clinical Trials Transformation Initiative.

Authors:  Philip Coran; Jennifer C Goldsack; Cheryl A Grandinetti; Jessie P Bakker; Marisa Bolognese; E Ray Dorsey; Kaveeta Vasisht; Adam Amdur; Christopher Dell; Jonathan Helfgott; Matthew Kirchoff; Christopher J Miller; Ashish Narayan; Dharmesh Patel; Barry Peterson; Ernesto Ramirez; Drew Schiller; Thomas Switzer; Liz Wing; Annemarie Forrest; Aiden Doherty
Journal:  Digit Biomark       Date:  2019-11-06

Review 2.  [Benefit assessment of digital health applications-challenges and opportunities].

Authors:  Lars G Hemkens
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-09-15       Impact factor: 1.513
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.